Ironwood Financial, llc - HTG MOLECULAR DIAGNOSTICS IN ownership

HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H104. A total of 22 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Ironwood Financial, llc ownership history of HTG MOLECULAR DIAGNOSTICS IN
ValueSharesWeighting
Q3 2020$1,0000.0%1,5710.0%0.00%0.0%
Q2 2020$1,0000.0%1,5710.0%0.00%0.0%
Q1 2020$1,0000.0%1,5710.0%0.00%
Q4 2019$1,0000.0%1,5710.0%0.00%
Q3 2019$1,000
-66.7%
1,5710.0%0.00%
-100.0%
Q2 2019$3,000
-25.0%
1,5710.0%0.00%
-50.0%
Q1 2019$4,0000.0%1,5710.0%0.00%0.0%
Q4 2018$4,000
-50.0%
1,571
-6.0%
0.00%
-50.0%
Q3 2018$8,000
-11.1%
1,671
-42.6%
0.00%
-20.0%
Q2 2018$9,000
+80.0%
2,911
+97.4%
0.01%0.0%
Q1 2018$5,000
+66.7%
1,4750.0%0.01%
+150.0%
Q4 2017$3,0000.0%1,4750.0%0.00%0.0%
Q3 2017$3,000
-25.0%
1,4750.0%0.00%
-33.3%
Q2 2017$4,000
-60.0%
1,4750.0%0.00%
-57.1%
Q1 2017$10,000
+66.7%
1,475
-44.8%
0.01%
+75.0%
Q4 2016$6,000
+200.0%
2,670
+206.9%
0.00%
+300.0%
Q3 2016$2,0000.0%8700.0%0.00%0.0%
Q2 2016$2,0000.0%8700.0%0.00%
-50.0%
Q1 2016$2,000
-71.4%
8700.0%0.00%
-33.3%
Q3 2015$7,000
+133.3%
870
+210.7%
0.00%
+200.0%
Q2 2015$3,0002800.00%
Other shareholders
HTG MOLECULAR DIAGNOSTICS IN shareholders Q4 2015
NameSharesValueWeighting ↓
Novo Holdings A/S 1,280,185$9,755,0001.01%
Cormorant Asset Management, LP 201,000$1,532,0000.24%
PUTNAM INVESTMENTS LLC 575,692$4,386,0000.01%
Alyeska Investment Group, L.P. 114,113$870,0000.01%
VANGUARD GROUP INC 4,355,424$131,473,0000.01%
BLACKROCK ADVISORS LLC 463,200$3,530,0000.00%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 26,100$199,000,0000.00%
Ironwood Financial, llc 870$7,0000.00%
PANAGORA ASSET MANAGEMENT INC 24,293$185,0000.00%
Sonora Investment Management, LLC 500$3,0000.00%
View complete list of HTG MOLECULAR DIAGNOSTICS IN shareholders